The Safety of Tiotropium " The FDA’s Conclusions | Health Policy and Reform

Links shared publicly online about this topic.

  • 888
    total visits

The Safety of Tiotropium " The FDA’s Conclusions | Health Policy and Reform

healthpolicyandreform.nejm.org

Theresa M. Michele, M.D., Simone Pinheiro, Sc.D., and Solomon Iyasu, M.D., M.P.H. Chronic obstructive pulmonary disease (COPD) is a leading cause of death

View full resource at healthpolicyandreform.nejm.org

Tags: COPD, COPD Medication, Disease and Condition, FDA, Spiriva, Pulmonology

  • Share

Most Recently Shared on September 19, 2010 at 2:33 pm By:

Also Shared By:

NEJM NEJM

Michael Oleyar Michael Oleyar

FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone - Drugs.com MedNews

drugs.com — “This update is in follow-up to the FDA Drug Safety Communication posted on 9 26 11 1 Safety review update on the possible increased risk of blood clots with birView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on April 11, 2012 at 1:02 pm By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth con... http://t.co/f0KHw6DC #drug

1 week ago...

Flaws in St. Jude Heart Defibrillator Shake the Industry - NYTimes.com

nytimes.com — “A problem with wires in a heart defibrillator is the industry’s third highly visible safety episode in seven years, inviting discussion of a greater role for the F.D.A.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on April 7, 2012 at 12:18 pm By:

drjohnm John Mandrola, MD Cardiologist, Physician, Doctor, and Internist

Us docs in social media have known about #Riata issues for some time. Now it's really serious; Mr Meier is in. http://t.co/XFdEyYem

2 weeks ago...

Weight loss pill Qnexa wins panel vote and awaits approval

news-medical.net — “The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often follows the advisory panel's advice, Qnexa is likely to get FDA approval, probably by mid-April.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 5, 2012 at 11:08 pm By:

Diet_News News-Medical.Net Health News

Diet News: Weight loss pill Qnexa wins panel vote and awaits approval: The drug was rejected in a 10-6 vote the ... http://t.co/rGbONdEq

2 weeks ago...

New diet drug Qnexa awaits FDA approval amid safety questions – USATODAY.com

usatoday.com — “Some experts say it could potentially help dieters lose about 10% of their weight, but with its former FDA rejection, how safe is it?View full resource at usatoday.com

  • View Related
  • Share

Most Recently Shared on April 4, 2012 at 10:45 pm By:

USATODAYhealth Maureen Linke Health News

Diet drug Qnexa awaits FDA approval amid safety questions http://t.co/YjlUT7Bn

2 weeks ago...

Consumer Reports Warns of Lax Testing for Medical Devices - ABC News

abcnews.go.com — “Consumer Reports advises patients to do their homework before having medical devices implanted in their bodies.  Companies that sell defibrillators, stents or other such products can get approval from the Food and Drug Administration without their undergoing rigorous testing, Consumer Reports warned in a new report. The FDA collects information on medical device malfunctions that lead to death. Data highlighted by Consumer Reports show 686 deaths from 2009 to last year connected to automateView full resource at abcnews.go.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 7:39 pm By:

HITpol HealthIT Policy Health IT and Health News

Consumer Reports Warns of Lax Testing for Medical Devices: Consumer Reports advises patients to do their homewor... http://t.co/z5sM68RZ

3 weeks ago...

PharmaLive: FDA Drug Safety Communication: Revised Recommendations for Celexa (citalopram hydrobromide) Related to a Potential Risk of Abnormal Heart Rhythms with High Doses

pharmalive.com — “PharmaLive: FDA Drug Safety Communication: Revised Recommendations for Celexa (citalopram hydrobromide) Related to a Potential Risk of Abnormal Heart Rhythms with High DosesView full resource at pharmalive.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 5:00 pm By:

pharmalive PharmaLive Health News and Pharma

FDA Issues Revised Recommendations for Celexa Related to a Potential Risk of Abnormal Heart Rhythms with High Doses http://t.co/PhAy1tsQ

3 weeks ago...

FDA Working To Reduce 'Alarm Fatigue' Through Tougher Device Reviews - iHealthBeat

ihealthbeat.org — “FDA is taking steps to curb 'alarm fatigue' in hospitals by increasing its pre-market scrutiny of medical devices that issue potentially unnecessary alarms. For example, the agency is providing its reviewers with additional training on alarm standards and safety. Boston Globe.View full resource at ihealthbeat.org

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 6:44 pm By:

iHealthBeat iHealthBeat.org Health Organization

FDA Working To Reduce 'Alarm Fatigue' Through Tougher Device Reviews - http://t.co/M8fjbpc5

4 weeks ago...

FDA working to trim hospital ‘alarm fatigue’ - Boston.com

bostonglobe.com — “The Food and Drug Administration is taking steps to reduce “alarm fatigue’’ in hospitals by intensifying its pre-market review of medical devices that sound alarms and could contribute to theView full resource at bostonglobe.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 5:15 pm By:

carybyrd Cary Byrd - eDrugSearch.com Health Advocate and Pharma

FDA working to trim hospital ‘alarm fatigue’ - Health & wellness - The Boston Globe http://t.co/OyKko7Cn

4 weeks ago...

An update on BPA science | Sarah Janssen's Blog | Switchboard, from NRDC

switchboard.nrdc.org — “As the end-of-the-month decision from the Food and Drug Administration on the safety of bisphenol A (BPA) draws closer, the chemical industry is trying hard to paint NRDC’s advocacy against the endocrine-disrupting substance in a bad light. Last week, on...View full resource at switchboard.nrdc.org

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 3:40 pm By:

Safe Handling of Pet Food in the Home (video)

fda.gov — “No matter whether you give your pet a commercially prepared diet or raw meat, this video describes how you can avoid problems if you follow some basic, commonsense, food safety guidelines.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 1:02 pm By:

NCStateVetMed NCState Vet Medicine Veterinarian

Do you practice safe pet foot handling? RT @AVMAvets: Video: Pet Food in the Home, from @US_FDA http://t.co/Rb2kGweI

4 weeks ago...

FDA working to trim hospital ‘alarm fatigue’ - Health & wellness - The Boston Globe

bostonglobe.com — “The US Food and Drug Administration is seeking to reduce “alarm fatigue’’ in hospitals by intensifying its pre-market review of medical devices that sound alarms and could contribute to the desensitization of nurses - a problem that the Globe reported last year was linked to hundreds of deaths. The agency is providing additional training on alarm standards and alarm safety to its reviewers, who are responsible for scrutinizing 4,000 applications a year from device manufacturers.View full resource at bostonglobe.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 12:25 pm By:

FDA working to trim hospital ‘alarm fatigue’ - Health & wellness - The Boston Globe

bostonglobe.com — “The US Food and Drug Administration is seeking to reduce “alarm fatigue’’ in hospitals by intensifying its pre-market review of medical devices that sound alarms and could contribute to the desensitization of nurses - a problem that the Globe reported last year was linked to hundreds of deaths. The agency is providing additional training on alarm standards and alarm safety to its reviewers, who are responsible for scrutinizing 4,000 applications a year from device manufacturers.View full resource at bostonglobe.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 12:02 pm By:

F.D.A. Asked DePuy for Safety Data Just Before Hip Implant’s Phaseout - NYTimes.com

nytimes.com — “Shortly after getting a request from the Food and Drug Administration for safety data about an artificial hip, Johnson & Johnson executives decided to discontinue making the device.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 11:41 am By:

KentBottles Kent Bottles, MD Doctor, Pathologist, and Physician

F.D.A. Asked DePuy for Safety Data Just Before Hip Implant’s Phaseout: http://t.co/SP1SVuVe

4 weeks ago...

FDA must prove safety of livestock drugs

azcentral.com — “FDA must prove safety of livestock drugs, Federal regulators must withdraw approval for some antibiotics used in livestock unless drugmakers can prove the products are safe.View full resource at azcentral.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 8:59 am By:

Hoodooed: Gulf of Mexico Seafood Safety according to the FDA and EPA

hoodooed.blogspot.com — “Green News, Environmentalism, Healing, Peace and Political Resistance in Florida. Since April of 2010, a news gathering space for the Crimes Against Humanity and Ecocide in the Gulf of Toxico and the after affects on the life here, flora, fauna and human. In support of OCCUPY MOVEMENTS EVERYWHERE!View full resource at hoodooed.blogspot.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 11:40 pm By:

Advertisement